Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/28/3090018/0/en/Nxera-Pharma-Notes-Neurocrine-Biosciences-Presents-New-Positive-Data-from-Phase-2-Study-of-NBI-1117568-in-Adults-with-Schizophrenia-at-American-Society-of-Clinical-Psychopharmacolo.html
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-positive-data-from-phase-2-study-of-nbi-1117568-in-adults-with-schizophrenia-at-american-society-of-clinical-psychopharmacology-2025-302467554.html
16 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-wide-ranging-one-year-data-from-phase-3-cahtalyst-pediatric-study-at-pediatric-endocrine-society-2025-annual-meeting-302457277.html
16 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-data-adding-to-the-growing-body-of-evidence-demonstrating-functional-and-quality-of-life-improvements-in-patients-with-tardive-dyskinesia-302457312.html
15 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-data-on-improvements-in-physiologic-glucocorticoid-dosing-and-select-reproductive-hormones-in-patients-with-classic-congenital-adrenal-hyperplasia-taking-crenessity-crinecerfont-302457026.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-findings-contributing-to-the-growing-body-of-evidence-on-the-impact-of-high-dose-glucocorticoids-on-clinical-outcomes-in-congenital-adrenal-hyperplasia-302455617.html
ABOUT THIS PAGE